Coave Therapeutics


Rodolphe Clerval, CEO

April 10 | 1:45pm | Salone dei Cavalieri, Section 2

Paris, France


Coave Tx is a genetic medicine company, based on a unique technology (ALIGATER) for functionalizing LNPs and AAVs, by conjugation of rationally designed ligands onto vectors surface, improving tissue targeting and efficient payload delivery. Our therapeutics pipeline, based on ALIGATER vectors, is focused on eyes and CNS disorders.

By using this website you agree to accept our Privacy Policy and Terms & Conditions